View More Recent Stories

Sep 23, 2024 02:57AM Guggenheim Starts Keros Therapeutics (KROS) at Buy
Jun 18, 2024 07:57AM Piper Sandler Reiterates Overweight Rating on Keros Therapeutics (KROS)
Jun 17, 2024 04:01PM Keros Therapeutics (KROS) Announces Leadership Updates
Jun 17, 2024 06:02AM Keros Therapeutics (KROS) Presents Clinical Data from KER-050 Program
View More Recent Stories